202 related articles for article (PubMed ID: 37462667)
1. Healthcare costs, resource utilization, and productivity loss associated with colorectal cancer screening.
Engel-Nitz NM; Miller-Wilson LA; Le L; Fisher DA
Expert Rev Pharmacoecon Outcomes Res; 2023; 23(7):843-852. PubMed ID: 37462667
[TBL] [Abstract][Full Text] [Related]
2. Multitarget stool DNA tests increases colorectal cancer screening among previously noncompliant Medicare patients.
Prince M; Lester L; Chiniwala R; Berger B
World J Gastroenterol; 2017 Jan; 23(3):464-471. PubMed ID: 28210082
[TBL] [Abstract][Full Text] [Related]
3. Colorectal cancer screening uptake and adherence by modality at a large tertiary care center in the United States: a retrospective analysis.
Cheney C; Parish A; Niedzwiecki D; Oko C; Walters C; Halpern D; Helmueller L; Hoyek NE; Miller-Wilson LA; Sullivan BA
Curr Med Res Opin; 2024 Mar; 40(3):431-439. PubMed ID: 38197407
[TBL] [Abstract][Full Text] [Related]
4. Colorectal cancer screening completion: An examination of differences by screening modality.
Finney Rutten LJ; Jacobson DJ; Jenkins GD; Fan C; Weiser E; Parks P; Doroshenk M; Limburg PJ; St Sauver JL
Prev Med Rep; 2020 Dec; 20():101202. PubMed ID: 32995145
[TBL] [Abstract][Full Text] [Related]
5. Early Adoption of a Multitarget Stool DNA Test for Colorectal Cancer Screening.
Finney Rutten LJ; Jacobson RM; Wilson PM; Jacobson DJ; Fan C; Kisiel JB; Sweetser S; Tulledge-Scheitel SM; St Sauver JL
Mayo Clin Proc; 2017 May; 92(5):726-733. PubMed ID: 28473037
[TBL] [Abstract][Full Text] [Related]
6. Estimated impact and value of blood-based colorectal cancer screening at varied adherence compared with stool-based screening.
Kisiel JB; Fendrick AM; Ebner DW; Ozbay AB; Vahdat V; Estes C; Limburg PJ
J Med Econ; 2024; 27(1):746-753. PubMed ID: 38686394
[TBL] [Abstract][Full Text] [Related]
7. Detection of Postcolonoscopy Colorectal Neoplasia by Multi-target Stool DNA.
Ebner DW; Eckmann JD; Burger KN; Mahoney DW; Bering J; Kahn A; Rodriguez EA; Prichard DO; Wallace MB; Kane SV; Finney Rutten LJ; Gurudu SR; Kisiel JB
Clin Transl Gastroenterol; 2021 Jun; 12(6):e00375. PubMed ID: 34140458
[TBL] [Abstract][Full Text] [Related]
8. Trends in Colorectal Cancer Screening from the National Health Interview Survey: Analysis of the Impact of Different Modalities on Overall Screening Rates.
Ebner DW; Finney Rutten LJ; Miller-Wilson LA; Markwat N; Vahdat V; Ozbay AB; Limburg PJ
Cancer Prev Res (Phila); 2024 Jun; 17(6):275-280. PubMed ID: 38561018
[TBL] [Abstract][Full Text] [Related]
9. Harms, benefits and costs of fecal immunochemical testing versus guaiac fecal occult blood testing for colorectal cancer screening.
Goede SL; Rabeneck L; van Ballegooijen M; Zauber AG; Paszat LF; Hoch JS; Yong JH; Kroep S; Tinmouth J; Lansdorp-Vogelaar I
PLoS One; 2017; 12(3):e0172864. PubMed ID: 28296927
[TBL] [Abstract][Full Text] [Related]
10. Influence of Colorectal Cancer Risk Factors on Predictive Value of a Positive Multitarget Stool DNA Test.
Narayani KR; Narayani RI
J Clin Gastroenterol; 2024 May-Jun 01; 58(5):471-474. PubMed ID: 37389965
[TBL] [Abstract][Full Text] [Related]
11. Impact of screening and follow-up colonoscopy adenoma sensitivity on colorectal cancer screening outcomes in the CRC-AIM microsimulation model.
Fisher DA; Saoud L; Hassmiller Lich K; Fendrick AM; Ozbay AB; Borah BJ; Matney M; Parton M; Limburg PJ
Cancer Med; 2021 Apr; 10(8):2855-2864. PubMed ID: 33314646
[TBL] [Abstract][Full Text] [Related]
12. Inappropriate Ordering of Multitarget Stool DNA Tests for Colon Cancer Screening.
Ahn AB; Kulhari S; Rhee J; Cooper G
J Am Board Fam Med; 2024; 37(2):328-331. PubMed ID: 38740492
[TBL] [Abstract][Full Text] [Related]
13. Multitarget Stool RNA Test for Colorectal Cancer Screening.
Barnell EK; Wurtzler EM; La Rocca J; Fitzgerald T; Petrone J; Hao Y; Kang Y; Holmes FL; Lieberman DA
JAMA; 2023 Nov; 330(18):1760-1768. PubMed ID: 37870871
[TBL] [Abstract][Full Text] [Related]
14. Fecal-based colorectal cancer screening among the uninsured in northern Manhattan.
Hillyer GC; Schmitt KM; Freedberg DE; Kramer RA; Su Y; Rosenberg RM; Neugut AI
Am J Prev Med; 2014 Aug; 47(2):182-7. PubMed ID: 24951037
[TBL] [Abstract][Full Text] [Related]
15. Quantified trends in provider reimbursement and utilization volume in colorectal cancer screenings: analysis of Medicare claims from 2000 to 2019.
Bommineni VM; Bommineni VL; Gupta R
Colorectal Dis; 2024 May; 26(5):1028-1037. PubMed ID: 38581083
[TBL] [Abstract][Full Text] [Related]
16. Screening for colorectal cancer with FOBT, virtual colonoscopy and optical colonoscopy: study protocol for a randomized controlled trial in the Florence district (SAVE study).
Sali L; Grazzini G; Carozzi F; Castiglione G; Falchini M; Mallardi B; Mantellini P; Ventura L; Regge D; Zappa M; Mascalchi M; Milani S
Trials; 2013 Mar; 14():74. PubMed ID: 23497601
[TBL] [Abstract][Full Text] [Related]
17. Colorectal Cancer Screening by Fecal Immunochemical Tests (FIT): Considerations on Sampling and Markers (Hb and Hb/Hp Complex) of Fecal Occult Blood (FOB).
Syrjänen K; Eskelinen M; Meklin J; Hendolin P; Eskelinen M; Suovaniemi O
Anticancer Res; 2024 Apr; 44(4):1513-1523. PubMed ID: 38537972
[TBL] [Abstract][Full Text] [Related]
18. Time to Colonoscopy After Abnormal Stool-Based Screening and Risk for Colorectal Cancer Incidence and Mortality.
San Miguel Y; Demb J; Martinez ME; Gupta S; May FP
Gastroenterology; 2021 May; 160(6):1997-2005.e3. PubMed ID: 33545140
[TBL] [Abstract][Full Text] [Related]
19. Life-years gained resulting from screening colonoscopy compared with follow-up colonoscopy after a positive stool-based colorectal screening test.
Mark Fendrick A; Borah BJ; Burak Ozbay A; Saoud L; Limburg PJ
Prev Med Rep; 2022 Apr; 26():101701. PubMed ID: 35106276
[TBL] [Abstract][Full Text] [Related]
20. Would initiating colorectal cancer screening from age of 45 be cost-effective in Germany? An individual-level simulation analysis.
Lwin MW; Cheng CY; Calderazzo S; Schramm C; Schlander M
Front Public Health; 2024; 12():1307427. PubMed ID: 38454984
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
